最高のファンコニー貧血医師 - トップ8名の医師

ザフェル・ギュルバシュ教授は血液腫瘍専門医であり、欧州最大規模のひとつに数えられるAnadolu Medical Center骨髄移植センターの創設者・センター長です。

患者がギュルバシュ医師を選び、信頼する理由：

• Anadolu骨髄移植センターをゼロから設立し、同センターでは3,000件以上の移植を実施（2010年以降）。
• 自家移植の成功率81%―センターデータにおける高い実績を示す指標。
• 国際的な研鑽：Hadassah（イスラエル）、Fred HutchおよびMD Anderson（米国）、Princess Margaret（カナダ）など主要センターでの研修・勤務経験を有する。
• 260件以上の学術論文および5,000件以上の被引用数―移植医学への多大な貢献を裏付ける。
• AnadoluクリニックはJohns Hopkins Medicine Internationalの公式提携施設であり、国際的な診療プロトコル・カンファレンス・質管理へのアクセスを保証。
• 白血病、リンパ腫、再生不良性貧血、凝固障害（血液凝固異常）など、最も難治性の高い症例を担当。

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

ブランカ・ロペス・イボール・アリーニョ博士は、スペイン出身の小児血液腫瘍学の経験豊富な専門家であり、国内でトップクラスの小児神経外科医の一人でもあります。重篤な血液および癌疾患を有する子供とティーンエイジャーのケアに重点を置くHMグループの血液・小児腫瘍ユニットを率いています。ロペス・イボール博士は30年以上の実務経験を持ち、WHOおよびユネスコのコンサルタントとして働いています。教育および研究活動を提供しています。

ブランカ・ロペス・イボール博士の専門分野

医師は、特に赤血球、骨髄系、およびリンパ系の診断に関連する血液学的および癌性疾患の診断と治療を専門としています。イボール博士が治療する全ての疾患プロフィールを見るには、下にスクロールしてください。

教育

• マドリード・コンプルテンセ大学（スペイン） — 小児科および新生児ケアの医学学位
• バルセロナ大学（スペイン） — 医学のポストドクトラル学位
• メリーランド大学（アメリカ合衆国） — 小児腫瘍専門医および血液専門医。

職歴

• HM Hospitalesの血液・小児腫瘍ユニットの責任者 — 2006年から
• サン・ラファエル病院の血液・小児腫瘍部門の責任者 — 1999-2006
• ラ・サルスエラ大学病院の医師 — 1994-1999
• カタルーニャ総合大学病院の助手医師 — 1988-1993
• ニーニョ・ヘスス児童大学病院の助手医師 — 1986-1987

その他の活動

ロペス・イボール博士は2004年からスペイン保健省の小児がんの専門家として活躍しています。

ブランカ・ロペス・イボール博士は、マドリード・コンプルテンセ大学およびCEUサン・パブロ大学で講師を務めています。

医師は次を率いています：

• ハイメ・アロンソ・アブルーニャ基金 — 重篤な健康問題を抱える子供たちを支援することに重点を置いている基金。
• Curarte 基金 — 治療中の子供たちの生活の質を向上させる組織。

組織への所属

• アメリカ血液学会 (ASH)
• アメリカ小児血液腫瘍学会
• 国際小児腫瘍学会 (SIOP)
• スペイン小児科学会。